This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)
C3_FEMALE_GENITAL_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
912 |
4. Check minimum number of eventsNone |
912 |
5. Include endpointsNone |
912 |
6. Filter based on genotype QC (FinnGen only) |
912 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 912 | 912 | - |
| Unadjusted period prevalence (%) | 0.31 | 0.31 | - |
| Median age at first event (years) | 67.18 | 67.18 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 401
- Matched controls
- 4010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
710.2
323.0
280
13
128
Kela drug reimbursment
Cancers of female genital organs
+∞
323.0
296
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
263.6
223
*
A04AA01
ATC
ondansetron; systemic, rectal
107.0
219.6
231
50
A03FA01
ATC
metoclopramide; systemic, rectal
41.1
213.2
314
323
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
210.5
183
*
JAL30
NOMESCO Finland
Omentectomy
985.0
190.6
172
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
183.9
162
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
147.2
132
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1955.9
145.1
132
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
140.0
126
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
70.0
138.3
156
36
R18
ICD-10 Finland
Ascites
222.4
136.1
134
9
B01AB10
ATC
tinzaparin; parenteral
31.4
132.6
183
104
JN4BD
NOMESCO Finland
Extensive body CT
32.1
123.3
168
88
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
115.3
105
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
115.3
105
*
Z51.5
ICD-10 Finland
Palliative care
68.3
109.4
124
26
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
30.4
106.4
146
74
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
1271.7
104.1
97
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
101.5
93
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
100.3
92
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
24.9
99.1
145
89
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
91.2
84
*
L02BG04
ATC
letrozole; oral
531.8
88.8
85
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
977.4
83.7
79
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
32.7
80.6
107
44
A04AA55
ATC
palonosetron, combinations; systemic
886.5
77.0
73
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
75.4
70
*
JEA00
NOMESCO Finland
Appendectomy
17.4
73.1
121
97
TPH07
NOMESCO Finland
Cathetrisation of artery
12.3
70.3
139
166
N02AA05
ATC
oxycodone; systemic
9.6
69.3
163
268
JAL00
NOMESCO Finland
Biopsy of peritoneum
207.5
68.4
69
*
LCD00
NOMESCO Finland
Hysterectomy
12.6
65.5
126
140
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
61.0
57
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
21.7
59.4
89
52
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
78.6
59.3
66
10
ZX120
NOMESCO Finland
Intravenous
12.2
57.9
112
123
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
56.6
53
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
56.6
53
*
C574, 8461, 3
ICD-O-3
NA
+∞
56.6
53
*
WW500
NOMESCO Finland
Blood transfusion
35.6
55.1
71
24
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.5
53.7
222
737
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.0
53.6
137
243
JN4AD
NOMESCO Finland
Body CT examination
18.3
53.5
85
58
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.2
53.4
74
33
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
53.3
50
*
115
Kela drug reimbursment
Breast cancer
+∞
53.3
50
*
A04AA02
ATC
granisetron; systemic, transdermal
198.4
51.2
52
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
51.1
48
*
B01AB05
ATC
enoxaparin; parenteral
5.1
50.3
230
834
JAH01
NOMESCO Finland
Laparoscopy
14.2
50.2
89
79
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
46.8
44
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
502.0
46.2
45
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
19.3
45.9
71
44
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
19.0
45.0
70
44
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
43.5
41
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
240.0
42.8
43
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
42.4
40
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
160.0
41.6
43
*
WX402
NOMESCO Finland
General anaesthesia
5.9
41.3
134
314
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
40.3
38
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.3
40.2
221
895
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
39.2
37
*
L03AA02
ATC
filgrastim; parenteral
402.7
37.7
37
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
37.1
35
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
58.4
36.2
42
8
130
Kela drug reimbursment
Malignant tumour
+∞
36.0
34
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
21.6
36.0
53
28
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
32.8
31
*
C579, 8461, 3
ICD-O-3
NA
+∞
32.8
31
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
25.8
31.7
44
19
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
31.7
30
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
31.7
30
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
50.8
31.2
37
8
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
30.6
29
*
Z31.5
ICD-10 Finland
Genetic counselling
12.1
29.6
55
52
X77
ICPC
Malignant neopl genital female other
+∞
29.5
28
*
TJA10
NOMESCO Finland
Laparocentesis
+∞
29.5
28
*
3009
Kela drug reimbursment
Niraparib
+∞
29.5
28
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
30.7
29.5
39
14
WF049
NOMESCO Finland
Radiotherapy of metastasis
313.5
29.2
29
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.1
29.1
139
463
1510
Kela drug reimbursment
Niraparib
+∞
28.5
27
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
28.5
27
*
JAH00
NOMESCO Finland
Laparotomy
17.5
27.9
44
28
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.2
27.7
45
31
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
27.4
26
*
1XC07
NOMESCO Finland
NA
+∞
27.4
26
*
HA1AA
NOMESCO Finland
X-ray mammography
7.9
26.9
64
94
L02BA01
ATC
tamoxifen; oral
+∞
26.3
25
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.7
25.0
60
89
JFB46
NOMESCO Finland
Resection of sigmoid colon
23.8
24.8
35
16
D70.82
ICD-10 Finland
Drug-induced neutropenia
132.9
23.9
25
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.1
23.3
47
52
HAC20
NOMESCO Finland
Total mastectomy
243.3
22.9
23
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
22.3
126
467
L01XK02
ATC
niraparib; oral
+∞
22.1
21
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
85.0
21.9
24
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.0
21.1
30
14
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
21.0
20
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
21.0
20
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
21.0
20
*
A79
ICPC
Malignancy NOS
+∞
21.0
20
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
21.0
20
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
21.0
20
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
21.5
20.7
30
15
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.7
20.6
40
41
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
20.0
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
77.2
19.9
22
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
30.8
19.9
26
9
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
19.7
86
255
JFB00
NOMESCO Finland
Partial resection of small intestine
33.2
19.5
25
8
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.6
19.2
51
87
C50.99
ICD-10 Finland
Breast, unspecified
+∞
18.9
18
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
18.9
18
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
18.9
18
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
198.9
18.7
19
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
11.5
18.3
34
32
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
34.7
18.2
23
7
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
17.8
17
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.8
17.3
40
56
WZC30
NOMESCO Finland
Teaching
4.4
17.2
66
172
K56.7
ICD-10 Finland
Ileus, unspecified
18.4
17.2
26
15
J94.8
ICD-10 Finland
Other specified pleural conditions
27.0
17.1
23
9
8441/3-C57.0
ICD-O-3
Serous carcinoma, NOS, of fallopian tube
+∞
16.8
16
*
1511
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
389
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
+∞
16.8
16
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
16.8
16
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
16.6
60
147
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.4
16.2
87
301
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
16.2
80
261
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
15.7
15
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
14.5
15.7
26
19
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.5
15.1
55
136
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
22.1
14.8
21
10
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
14.7
14
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
155.4
14.6
15
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.3
14.5
79
275
JN3AD
NOMESCO Finland
Abdominal CT examination
4.1
14.5
58
157
JFB30
NOMESCO Finland
Right hemicolectomy
28.4
14.4
19
7
LCA06
NOMESCO Finland
Biopsy of endometrium
3.0
14.4
95
380
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
44.2
14.2
17
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.4
14.1
24
19
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.6
13
*
ZXC40
NOMESCO Finland
Use of ultrasound
33.2
12.7
16
5
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
12.6
12
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
12.6
12
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
12.6
12
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
12.6
12
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
12.6
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
134.0
12.5
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
12.2
204
1302
A02BC02
ATC
pantoprazole; systemic
2.3
12.0
300
2277
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
17.1
11.8
18
11
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
19.6
11.7
17
9
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
11.6
11.7
21
19
R50.9
ICD-10 Finland
Fever, unspecified
3.2
11.6
65
230
A04AA03
ATC
tropisetron; systemic
+∞
11.5
11
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
11.5
11
*
8380/3-C57.0
ICD-O-3
Endometrioid adenocarcinoma, NOS, of fallopian tube
+∞
11.5
11
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
123.4
11.5
12
*
JFF10
NOMESCO Finland
Loop enterostomy
123.4
11.5
12
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
17.7
11.3
17
10
SPAT1109
SPAT
Analgesia with portable analgesic pump
28.9
10.8
14
5
B03XA02
ATC
darbepoetin alfa; parenteral
13.4
10.7
18
14
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
10.6
114
590
L02BG03
ATC
anastrozole; oral
112.8
10.5
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
10.5
10
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
+∞
10.5
10
*
GAE03
NOMESCO Finland
Suture of chest wall
+∞
10.5
10
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
10.5
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.5
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.5
10
*
8140/3-C57.0
ICD-O-3
Adenocarcinoma, NOS, of fallopian tube
+∞
10.5
10
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
10.5
10
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
10.5
10
*
JFF23
NOMESCO Finland
Transversostomy
33.5
10.4
13
*
Z93.3
ICD-10 Finland
Colostomy status
33.5
10.4
13
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
19.4
10.3
15
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
10.3
66
255
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
9.8
49
160
WF004
NOMESCO Finland
Palliative radiotherapy
56.4
9.7
11
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
102.3
9.5
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
102.3
9.5
10
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
102.3
9.5
10
*
L01XK01
ATC
olaparib; oral
+∞
9.4
9
*
8140/3-C57.9
ICD-O-3
Adenocarcinoma, NOS, of female genital tract, NOS
+∞
9.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
9.4
9
*
L01XX46
ATC
[U] olaparib; oral
+∞
9.4
9
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
9.4
9
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
9.4
9
*
8000/3-C57.9
ICD-O-3
Neoplasm, malignant of female genital tract, NOS
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.8
9.1
369
3226
WF002
NOMESCO Finland
Radical radiotherapy
37.6
9.1
11
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
19.1
9.0
13
7
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
24.7
9.0
12
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.8
8.9
17
18
R4190
NOMESCO Finland
Nutritional therapy
6.7
8.6
21
33
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
28.2
8.5
11
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
28.2
8.5
11
*
WX892
NOMESCO Finland
Monitored bed care
3.4
8.5
41
131
A04AD12
ATC
aprepitant; systemic
91.9
8.4
9
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
91.9
8.4
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.4
168
1103
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
8.4
8
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
8.4
8
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
8.4
8
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
8.4
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.4
8
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
8.4
8
*
JFF30
NOMESCO Finland
Other colostomy
+∞
8.4
8
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
8.4
8
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.4
8
*
WX704
NOMESCO Finland
Intubation
3.4
8.2
39
123
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.4
7.9
13
10
D25
ICPC
Abdominal distension
7.2
7.9
18
26
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
7.8
33
95
JFA80
NOMESCO Finland
Suture of colon
45.9
7.7
9
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
45.9
7.7
9
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
18.8
7.6
11
6
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
7.6
29
76
KBV10
NOMESCO Finland
Removal of stent from ureter
25.6
7.6
10
*
S18
ICPC
Laceration/cut
1.8
7.6
182
1256
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
81.5
7.4
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
81.5
7.4
8
*
ZX100
NOMESCO Finland
Oral
13.7
7.4
12
9
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
7.3
7
*
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
7.3
7
*
L01XX54
ATC
[U] niraparib; oral
+∞
7.3
7
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
7.3
7
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
X81
ICPC
Genital neopl female other/unspecif
+∞
7.3
7
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
7.3
7
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.6
7.3
31
90
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
16.1
7.3
11
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
7.2
37
124
M54.5
ICD-10 Finland
Low back pain
0.5
7.2
57
1043
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
7.2
61
277
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
30.6
7.2
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.7
6.8
28
79
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
40.7
6.8
8
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
40.7
6.8
8
*
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
40.7
6.8
8
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.9
6.7
9
*
Z51.88
ICD-10 Finland
Other specified medical care
5.7
6.7
18
33
ZXC96
NOMESCO Finland
Robot assisted procedure
12.5
6.6
11
9
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.5
6.5
18
34
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
70.9
6.4
7
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
70.9
6.4
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
70.9
6.4
7
*
R4110
NOMESCO Finland
Physiotherapy
1.9
6.3
113
699
A06AH03
ATC
naloxegol; oral
18.4
6.3
9
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
6.3
41
162
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
+∞
6.3
6
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
6.3
6
*
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
JFB43
NOMESCO Finland
Left hemicolectomy
27.1
6.2
8
*
WX600
NOMESCO Finland
Single shot through catheter
27.1
6.2
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
6.1
182
1319
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
6.1
24
66
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
375
191
32.65
307.65
1.7
1.5
812.5
67.3
pmol/l
19.09
362
186
732
424
83.41
307.65
20.2
1.6
250.6
23.0
u/ml
5.63
725
403
505
474
22.63
307.65
2.0
1.4
7.0
3.2
ug/l
0.84
304
355
230
178
16.94
250.15
1.8
1.8
71.7
133.1
u/ml
0.28
185
146
425
1064
6.61
174.78
6.7
2.2
0.8
0.8
mmol/l
11.00
414
965
81
13
68.28
147.60
1.3
3.2
7983.7
211268.0
e6/l
—
29
5
157
159
11.72
141.67
1.6
2.4
3.8
3.4
g/l
1.63
157
153
712
3353
6.12
128.55
6.7
3.4
31.9
35.8
g/l
46.36
702
3057
699
3250
5.93
127.96
5.0
3.4
—
—
—
0
0
304
752
5.56
121.20
6.1
5.5
0.2
1.4
mmol/l
6.57
276
584
303
757
5.50
119.24
6.1
5.5
5.2
5.1
kpa
0.83
297
720
302
757
5.47
118.30
6.1
5.5
16.7
11.8
kpa
27.45
296
717
145
174
9.72
114.95
1.6
2.1
91.9
93.4
%
0.25
145
158
774
4176
6.64
111.11
29.1
6.5
3.6
4.1
e9/l
10.12
660
3523
730
3761
5.72
110.75
11.3
3.4
9.1
10.7
umol/l
2.13
719
3482
443
1629
4.34
104.66
2.9
2.0
—
—
—
0
0
233
620
4.70
82.22
6.5
6.0
111.5
119.1
g/l
8.89
227
595
66
45
15.73
74.85
1.4
1.4
19962.1
166009.0
e6/l
0.44
33
22
69
53
14.00
73.21
1.4
1.4
1240.0
1616.7
e6/l
0.40
46
38
61
44
14.79
67.00
1.1
1.2
—
—
—
0
0
78
88
9.60
64.02
1.7
1.9
40.2
53.9
u/ml
0.18
72
81
109
184
6.59
63.23
1.5
1.7
—
—
—
0
0
220
681
3.94
61.98
2.3
2.0
31.7
34.6
u/l
0.41
190
565
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
106
182
6.46
60.41
2.4
2.7
0.3
0.4
u/ml
0.53
44
115
43
19
23.70
59.26
1.7
1.1
49.8
18.4
u/ml
2.08
43
19
624
3698
3.18
58.10
6.3
4.6
1.2
1.2
mmol/l
29.98
596
3237
514
2764
2.97
56.59
5.8
2.1
2.4
2.4
mmol/l
2.82
488
2269
184
560
3.86
52.49
1.8
1.9
0.2
0.2
g/l
1.00
163
519
420
2103
2.85
51.58
3.5
3.0
0.9
0.5
e6/l
0.75
299
1549
286
1182
3.07
49.74
3.2
2.6
3.7
4.6
e6/l
0.56
134
592
136
352
4.37
48.27
6.5
5.4
24.6
25.2
mmol/l
1.24
136
352
196
656
3.53
48.23
6.7
1.4
63.6
67.1
g/l
7.38
190
581
634
4114
2.78
44.06
6.7
5.0
1.2
1.2
mmol/l
34.04
570
3468
625
4081
2.69
41.92
12.9
5.6
0.0
0.0
estimate
0.00
126
677
628
4111
2.69
41.89
8.8
4.2
0.0
0.0
estimate
1.08
135
680
807
6062
3.88
41.44
12.7
5.3
91.5
76.4
u/l
7.03
789
5547
288
1310
2.75
40.79
3.1
2.5
1.9
1.8
e6/l
0.03
138
721
198
758
3.06
38.37
2.5
2.0
7.8
5.8
umol/l
0.61
168
643
657
4537
2.60
36.84
6.0
3.8
6.7
6.7
mmol/l
0.30
639
4191
405
2281
2.40
35.54
7.5
2.5
48.8
31.0
u/l
0.49
397
2160
738
5447
2.86
35.21
6.9
5.1
652.8
4133.2
e6/l
1.80
15
67
25
11
23.34
34.20
1.8
2.4
—
—
—
0
0
60
106
5.99
32.92
1.3
1.3
—
—
—
0
0
627
7681
0.41
31.22
5.0
6.3
39.5
40.0
mmol/mol
0.97
570
7038
192
827
2.67
29.21
1.6
1.7
—
—
—
0
0
126
433
3.22
28.92
7.8
6.1
25.1
24.9
mmol/l
0.19
120
396
191
832
2.64
28.34
1.6
1.7
—
—
—
0
0
580
4039
2.20
28.00
9.2
4.2
0.0
0.0
estimate
0.00
123
683
136
504
3.00
27.36
1.6
1.6
—
—
—
0
0
528
3594
2.11
26.39
7.0
5.8
24.3
28.8
%
13.73
508
3277
308
1708
2.21
26.31
1.7
1.7
2.4
1.2
mg/l
6.23
275
1310
293
1603
2.22
25.79
2.6
2.5
9.2
7.8
e6/l
0.53
257
1379
714
8200
0.40
25.43
4.4
5.5
2.9
2.8
mmol/l
2.40
624
7436
694
8013
0.44
22.62
3.8
4.9
5.0
4.8
mmol/l
2.73
617
7298
686
7948
0.45
22.25
3.6
4.8
1.6
1.6
mmol/l
0.74
608
7193
286
1633
2.09
21.97
3.2
2.3
2.5
2.5
mmol/l
12.93
265
1406
387
2491
1.96
21.04
3.8
2.2
57.6
59.1
u/l
0.23
368
2245
273
1560
2.07
20.74
3.2
3.9
61.1
265.8
ng/l
2.82
218
1243
105
396
2.87
20.26
1.6
1.4
—
—
—
0
0
24
27
9.10
19.49
1.5
1.2
32.5
15.4
ug/l
0.97
24
27
218
1171
2.13
19.34
1.7
1.7
—
—
—
0
0
184
930
2.23
19.00
2.2
2.4
21.6
22.0
%
0.13
158
781
112
453
2.68
18.88
1.6
1.7
—
—
—
0
0
62
184
3.54
17.82
1.9
2.9
—
—
—
0
0
74
250
3.13
17.30
4.8
3.4
1.6
1.4
mmol/l
0.31
74
243
33
61
5.58
17.23
1.6
1.8
2.7
3536.2
u/l
0.50
19
26
176
910
2.16
17.03
3.7
3.8
1.0
1.0
mmol/l
0.36
167
818
273
1676
1.90
16.23
1.3
1.4
—
—
—
0
0
667
7662
0.52
15.97
3.3
4.3
1.3
1.3
mmol/l
1.10
589
6846
15
14
10.88
13.78
1.3
1.1
4.6
1.8
mmol/l
2.58
15
14
146
759
2.10
13.75
3.7
3.1
—
—
—
0
0
721
8026
0.51
13.72
4.5
5.1
5.9
5.9
mmol/l
0.76
649
7214
40
1171
0.31
12.93
3.9
5.0
31.7
34.2
%
0.93
27
736
79
325
2.57
12.80
4.7
3.2
24.7
24.5
mmol/l
0.29
74
288
125
666
2.02
10.91
4.0
3.0
1.9
2.2
mmol/l
0.45
107
553
696
7732
0.58
10.39
5.4
5.5
2.0
2.1
mu/l
0.32
629
6993
43
145
3.06
10.12
1.3
1.3
—
—
—
0
0
43
145
3.06
10.12
1.3
1.3
—
—
—
0
0
851
7801
2.36
9.95
26.6
12.3
40.0
20.2
mg/l
45.99
812
5993
26
68
3.91
9.01
4.3
1.4
7.0
1940.0
u/ml
0.51
26
68
10
10
10.10
8.65
1.3
1.1
—
—
—
0
0
161
2431
0.59
8.39
1.5
1.6
1.4
1.3
mmol/l
0.74
141
2027
39
140
2.87
8.26
1.4
1.6
—
—
—
0
0
37
132
2.88
7.93
1.1
1.3
—
—
—
0
0
595
6747
0.66
7.77
4.6
4.6
15.2
15.0
pmol/l
1.28
543
6085
297
3854
0.66
7.75
2.0
2.3
78.2
81.9
nmol/l
1.36
258
3372
159
1037
1.65
7.02
10.6
26.9
1.1
1.3
inr
—
8
147
284
2128
1.49
6.75
9.5
4.7
0.0
0.0
estimate
0.00
124
687
265
1982
1.48
6.28
1.8
2.3
2.9
3.0
mg/l
0.44
219
1667
102
1598
0.59
5.84
1.2
1.3
28.0
41.3
iu/ml
0.54
28
511
748
6830
1.53
5.66
38.2
14.2
36.1
38.5
%
17.65
555
4446
15
39
3.89
5.28
2.4
1.5
—
—
—
0
0
102
1556
0.61
5.19
1.1
1.3
11.7
14.4
u/ml
0.22
32
575
42
221
1.94
3.88
1.1
1.2
—
—
—
0
0
14
46
3.08
3.54
1.4
1.5
0.1
0.3
nmol/l
—
8
36
80
524
1.58
3.48
5.3
2.8
4.4
4.5
pmol/l
0.19
73
445
91
620
1.52
3.33
6.7
2.3
57.5
65.0
ml/min/173m2
1.51
48
253
129
1709
0.71
3.13
1.7
1.7
1132.9
1194.3
nmol/l
0.36
97
1237
516
4633
1.26
3.01
4.7
2.9
57.7
41.8
u/l
2.51
479
4199
27
139
1.97
2.72
7.9
3.4
60.0
57.8
%
0.33
27
139
233
2779
0.78
2.65
3.7
3.8
22.0
7.8
mg/mmol
2.80
145
1547
35
588
0.58
2.63
1.2
1.2
99.9
134.3
iu/ml
0.36
13
227
7
15
4.69
2.60
1.4
1.2
—
—
—
0
0
26
469
0.54
2.52
1.4
1.7
—
—
—
0
0
23
116
2.01
2.47
1.2
1.3
—
—
—
0
0
19
89
2.16
2.46
1.1
1.3
—
—
—
0
0
12
45
2.69
2.45
2.0
1.7
—
—
—
0
0
297
2566
1.23
2.27
2.6
2.9
1750.4
1200.3
ng/l
0.49
271
2165
229
2692
0.80
2.23
2.0
2.1
125.4
170.2
u/l
1.69
220
2520
37
579
0.62
2.13
1.4
1.5
1.3
1.4
%
0.21
27
487
786
7541
1.31
2.08
36.7
11.5
76.2
75.5
ml/min/173m2
0.49
675
5955
7
20
3.52
2.06
1.9
1.3
—
—
—
0
0
14
287
0.48
2.05
1.3
1.9
—
—
—
0
0
329
3699
0.83
2.03
2.1
2.0
92.4
99.6
pmol/l
2.47
186
1648
25
140
1.81
2.02
1.8
2.2
15.1
16.2
%
0.62
14
68
231
2686
0.81
2.00
3.2
3.0
5.9
6.1
mmol/l
0.36
200
2223
24
136
1.79
1.88
4.0
4.0
4.7
5.1
kpa
1.33
24
136
24
137
1.77
1.84
8.3
3.1
4.9
4.1
e9/l
0.30
24
137
25
145
1.74
1.83
1.1
1.2
255.3
230.0
miu/ml
—
7
58
25
145
1.74
1.83
2.0
2.6
8.1
8.0
kpa
0.14
25
135
9
35
2.59
1.80
1.6
1.3
—
—
—
0
0
22
124
1.79
1.77
1.2
1.3
—
—
—
0
0
854
8327
1.40
1.73
39.7
14.7
138.8
139.8
mmol/l
27.46
848
8080
27
163
1.68
1.73
1.2
1.2
39.3
35.5
iu/l
0.31
22
146
8
30
2.68
1.72
1.1
1.2
47.5
31.7
umol/l
—
8
30
40
267
1.52
1.71
1.2
1.1
—
—
—
0
0
344
3085
1.18
1.70
8.9
4.5
—
—
—
0
0
855
8346
1.39
1.64
39.6
14.9
3.9
4.0
mmol/l
2.18
849
8085
9
187
0.48
1.63
1.2
1.1
—
—
—
0
0
224
1946
1.20
1.57
2.5
2.1
3752.4
6226.4
umol/l
0.45
202
1616
15
78
1.94
1.55
1.1
1.3
—
—
—
0
0
0
43
0.00
1.52
0.0
1.1
—
1.1
—
0
22
0
44
0.00
1.51
0.0
1.3
—
—
—
0
0
9
185
0.48
1.51
1.2
1.8
—
—
—
0
0
12
230
0.52
1.50
1.5
1.4
—
—
—
0
0
14
255
0.54
1.49
1.1
1.3
—
2.5
—
0
28
39
269
1.47
1.46
1.2
1.1
—
—
—
0
0
7
155
0.45
1.43
1.0
1.6
0.9
0.7
nmol/l
—
7
120
16
275
0.57
1.40
1.1
1.3
—
40.0
—
0
23
590
6203
0.86
1.35
3.3
4.5
19.5
13.1
mm/h
11.96
544
5712
15
259
0.57
1.35
1.3
1.6
—
338.1
—
0
21
19
307
0.61
1.33
1.2
1.6
—
—
—
0
0
18
284
0.63
1.16
2.5
1.8
—
—
—
0
0
5
20
2.51
1.15
2.2
3.0
—
—
—
0
0
5
20
2.51
1.15
2.2
3.0
—
—
—
0
0
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
23
337
0.67
1.07
1.7
2.0
38.4
40.3
u/l
0.14
15
294
17
263
0.64
1.03
1.4
1.6
—
—
—
0
0
12
202
0.59
1.02
1.1
1.2
—
5.9
—
0
19
12
68
1.77
1.01
1.2
1.3
—
—
—
0
0
13
76
1.72
0.99
1.4
1.3
—
—
—
0
0
18
271
0.66
0.97
2.2
1.8
—
—
—
0
0
0
30
0.00
0.97
0.0
4.7
—
—
—
0
0
12
69
1.75
0.96
1.2
1.2
—
—
—
0
0
16
246
0.64
0.95
1.4
1.8
1.1
1.2
g/l
0.56
16
231
15
93
1.62
0.94
1.3
1.8
90.5
89.9
%
0.22
15
93
19
279
0.67
0.92
1.2
1.5
—
—
—
0
0
205
1849
1.14
0.90
6.3
4.7
1.0
1.0
kg/l
0.51
22
287
11
182
0.60
0.90
1.7
1.4
—
—
—
0
0
22
152
1.46
0.88
1.1
1.1
—
—
—
0
0
10
56
1.79
0.88
3.7
1.4
—
—
—
0
0
39
299
1.32
0.87
2.1
1.6
1.9
1.6
g/l
0.79
34
263
338
3151
1.12
0.86
3.2
3.7
52.2
63.6
ng/l
0.13
251
2217
86
729
1.20
0.83
1.9
2.9
161.8
175.7
ng/l
0.21
81
662
169
1880
0.88
0.83
1.6
1.7
54676773.6
29559373.1
pmol/l
0.18
139
1519
227
2075
1.13
0.81
1.6
1.5
20.3
22.5
nmol/l
1.59
210
1721
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
14
91
1.55
0.75
1.4
1.3
—
—
—
0
0
12
77
1.57
0.68
2.9
3.7
—
—
—
0
0
24
179
1.35
0.67
1.3
1.3
—
—
—
0
0
5
30
1.67
0.61
2.2
2.1
241.4
202.0
u/l
—
5
30
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
10
64
1.57
0.58
1.0
1.0
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
5
86
0.58
0.56
1.2
1.1
—
69.6
—
0
7
9
62
1.46
0.53
1.4
1.3
—
—
—
0
0
31
251
1.24
0.51
1.8
2.1
113.9
1225.3
ug/l
0.78
31
233
850
8417
1.15
0.45
25.2
9.5
21.9
22.8
u/l
1.34
841
8011
429
4143
1.07
0.43
2.4
2.4
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
82.4
—
0
18
5
35
1.43
0.39
1.6
2.0
—
—
—
0
0
11
80
1.38
0.38
1.8
1.8
32.6
32.3
pg
0.08
11
80
5
36
1.39
0.38
1.2
1.5
—
—
—
0
0
16
202
0.79
0.37
1.8
1.6
24197.4
11727.5
e6/l
1.01
11
143
107
1155
0.92
0.35
10.5
6.6
—
—
—
0
0
10
132
0.75
0.32
1.1
1.2
—
—
—
0
0
44
390
1.13
0.31
1.2
1.3
—
—
—
0
0
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
7
97
0.72
0.31
1.3
1.1
—
—
—
0
0
28
241
1.17
0.29
1.4
1.4
247.4
302.6
ug/g
1.35
20
133
8
107
0.75
0.29
1.4
1.2
—
—
—
0
0
7
57
1.23
0.29
2.0
2.3
—
—
—
0
0
8
65
1.23
0.27
1.3
1.2
—
—
—
0
0
8
65
1.23
0.27
1.3
1.2
—
—
—
0
0
8
66
1.21
0.26
1.3
1.2
—
—
—
0
0
8
66
1.21
0.26
1.3
1.2
—
—
—
0
0
8
66
1.21
0.26
1.3
1.2
—
—
—
0
0
5
73
0.68
0.26
1.0
1.0
471.6
373.1
ng/l
—
5
50
5
74
0.67
0.26
1.0
1.0
60.8
55.4
ng/l
—
5
51
5
74
0.67
0.26
1.0
1.0
683.6
712.8
ng/l
—
5
49
21
245
0.85
0.25
1.4
1.7
—
—
—
0
0
18
152
1.19
0.24
1.2
1.2
—
0.4
nmol/l
—
0
7
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
5
39
1.28
0.23
1.0
1.2
13.2
16.3
u/l
—
5
33
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
16
188
0.85
0.21
1.0
1.2
3.7
3.9
mmol/l
0.69
16
177
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
4.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
76
712
1.07
0.21
2.3
2.4
3.8
6.0
ug/l
1.25
64
615
17
145
1.18
0.20
1.4
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
27
241
1.12
0.19
2.2
1.8
6.5
5.3
iu/l
0.34
14
71
43
397
1.09
0.17
3.3
3.2
1.9
2.2
mmol/l
0.24
33
294
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
12
101
1.19
0.16
1.8
1.5
—
—
—
0
0
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
181
1861
0.97
0.14
1.1
1.3
1.3
1.9
u/ml
0.29
45
459
30
326
0.92
0.14
1.6
1.4
8.6
10.3
g/l
1.82
25
269
861
8640
0.94
0.14
52.9
18.8
4.0
4.4
e12/l
74.92
830
8296
9
107
0.84
0.13
1.3
1.2
—
—
—
0
0
9
108
0.83
0.13
1.3
1.2
—
—
—
0
0
11
95
1.16
0.11
1.0
1.0
—
—
—
0
0
17
153
1.11
0.11
1.2
1.2
0.6
0.7
nmol/l
0.21
17
148
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
26
242
1.08
0.09
1.8
1.5
25.8
37.4
mg/l
2.84
21
202
5
47
1.06
0.09
1.0
1.0
399.8
224.3
mg/l
—
5
41
77
744
1.04
0.09
3.9
1.8
423.6
361.9
nmol/l
1.68
71
664
6
54
1.11
0.09
1.2
1.2
—
—
—
0
0
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
6
74
0.81
0.07
1.0
1.2
56.5
59.3
u/l
—
6
52
107
1094
0.98
0.07
1.4
1.4
—
—
—
0
0
8
91
0.88
0.06
1.1
1.1
—
—
—
0
0
22
234
0.94
0.06
1.2
1.5
0.0
0.1
iu/ml
—
9
41
9
100
0.90
0.06
2.3
1.6
353.7
333.4
mu/l
—
9
89
9
102
0.88
0.06
1.3
1.2
—
—
—
0
0
9
103
0.87
0.06
1.3
1.2
—
—
—
0
0
9
104
0.86
0.06
1.3
1.2
—
—
—
0
0
11
120
0.92
0.05
1.3
1.4
—
—
—
0
0
33
343
0.96
0.05
1.6
1.4
—
—
—
0
0
33
343
0.96
0.05
1.6
1.4
3.8
3.8
g/l
0.01
26
241
33
343
0.96
0.05
1.6
1.4
7.7
7.6
g/l
0.14
26
252
67
655
1.02
0.04
3.3
2.7
1.2
1.2
mmol/l
0.13
60
545
45
439
1.03
0.03
1.1
1.1
—
—
—
0
0
25
242
1.03
0.02
1.9
1.5
20.2
54.1
mg/l
0.87
20
200
33
322
1.03
0.02
1.6
1.4
3.5
3.0
g/l
1.05
26
250
20
207
0.97
0.01
1.1
1.2
554.2
470.5
mg/l
0.35
20
195
11
116
0.95
0.00
1.1
1.3
—
—
—
0
0
16
166
0.96
0.00
1.6
1.6
—
—
—
0
0
326
3253
1.00
0.00
2.4
2.7
204.7
97.0
ug/l
10.00
306
2948
26
256
1.02
0.00
1.5
1.4
0.0
0.0
g/l
0.50
26
235
34
338
1.01
0.00
1.1
1.4
—
—
—
0
0
24
235
1.02
0.00
1.5
1.4
0.0
0.0
g/l
0.00
24
219
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
24
240
1.00
0.00
1.5
1.4
0.0
0.0
g/l
0.00
24
220
0
5
0.00
0.00
0.0
1.0
—
7.3
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
21.0
—
0
5
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
49.1
—
0
6
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
7
77
0.91
0.00
1.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
8
89
0.90
0.00
1.3
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
13.2
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
38.7
—
0
5
5
49
1.02
0.00
10.0
2.4
13.4
13.4
%
—
5
49
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FEMALE_GENITAL_NAS_EXALLC – Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).